Tearsheet

Usana Health Sciences (USNA)


Market Price (5/14/2026): $17.645 | Market Cap: $324.6 Mil
Sector: Consumer Staples | Industry: Packaged Foods & Meats

Usana Health Sciences (USNA)


Market Price (5/14/2026): $17.645
Market Cap: $324.6 Mil
Sector: Consumer Staples
Industry: Packaged Foods & Meats

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -46%

Low stock price volatility
Vol 12M is 46%

Megatrend and thematic drivers
Megatrends include Health & Wellness Trends. Themes include Nutritional Supplements, Organic & Natural Products, and Functional Foods & Beverages.

Weak multi-year price returns
2Y Excs Rtn is -104%, 3Y Excs Rtn is -153%

Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 39x

Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.5%

Key risks
USNA key risks include [1] challenges attracting and retaining customers and distributors linked to a new compensation plan, Show more.

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -46%
1 Low stock price volatility
Vol 12M is 46%
2 Megatrend and thematic drivers
Megatrends include Health & Wellness Trends. Themes include Nutritional Supplements, Organic & Natural Products, and Functional Foods & Beverages.
3 Weak multi-year price returns
2Y Excs Rtn is -104%, 3Y Excs Rtn is -153%
4 Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 39x
5 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.5%
6 Key risks
USNA key risks include [1] challenges attracting and retaining customers and distributors linked to a new compensation plan, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Usana Health Sciences (USNA) stock has lost about 20% since 1/31/2026 because of the following key factors:

1. Q4 2025 Earnings Miss and Profitability Decline Sparked Initial Downturn.

Usana Health Sciences reported a net loss of $1.8 million for Q4 2025, a significant decline from net earnings of $4.5 million in Q4 2024, with diluted EPS falling to -$0.10 from $0.23 in the prior year. While adjusted EPS of $0.60 beat analyst estimates, revenue of $226.2 million missed expectations by approximately $4.28 million. The quarter also saw a higher-than-expected income tax expense of $5.8 million, largely due to one-time impairment and cost realignment charges, which was about $3.1 million greater than anticipated. Following this announcement on February 17, 2026, USNA shares declined 8.0%, closing at $19.00 on February 18, 2026.

2. Continued Decline in Core Nutritional Customer Base and Overall Profitability in Q1 2026.

In the first quarter of 2026, USANA's net earnings decreased to $7.5 million from $9.4 million a year ago, representing a 20% decline, and diluted EPS fell 16% to $0.41 from $0.49. Although overall net sales remained flat year-over-year at $250.2 million and beat analyst estimates, the Core Nutritional segment experienced a 12% year-over-year decline in active customers, totaling 404,000. Additionally, Hiya Active Monthly Subscribers decreased to 186,000 from 224,000 in Q1 2025. This continued decline in the foundational customer base signals ongoing challenges in the company's core business, despite growth in the newer Rise Wellness segment, which surged 741% to $14 million.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -18.8% change in USNA stock from 1/31/2026 to 5/13/2026 was primarily driven by a -51.4% change in the company's Net Income Margin (%).
(LTM values as of)13120265132026Change
Stock Price ($)21.7017.61-18.8%
Change Contribution By: 
Total Revenues ($ Mil)9139261.5%
Net Income Margin (%)1.8%0.9%-51.4%
P/E Multiple23.539.065.6%
Shares Outstanding (Mil)1818-0.6%
Cumulative Contribution-18.8%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 5/13/2026
ReturnCorrelation
USNA-18.8% 
Market (SPY)7.6%31.1%
Sector (XLP)2.0%36.9%

Fundamental Drivers

The -16.7% change in USNA stock from 10/31/2025 to 5/13/2026 was primarily driven by a -76.2% change in the company's Net Income Margin (%).
(LTM values as of)103120255132026Change
Stock Price ($)21.1517.61-16.7%
Change Contribution By: 
Total Revenues ($ Mil)8999263.0%
Net Income Margin (%)3.8%0.9%-76.2%
P/E Multiple11.539.0238.3%
Shares Outstanding (Mil)19180.6%
Cumulative Contribution-16.7%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 5/13/2026
ReturnCorrelation
USNA-16.7% 
Market (SPY)9.5%29.1%
Sector (XLP)12.6%35.2%

Fundamental Drivers

The -37.3% change in USNA stock from 4/30/2025 to 5/13/2026 was primarily driven by a -81.7% change in the company's Net Income Margin (%).
(LTM values as of)43020255132026Change
Stock Price ($)28.0917.61-37.3%
Change Contribution By: 
Total Revenues ($ Mil)8559268.4%
Net Income Margin (%)4.9%0.9%-81.7%
P/E Multiple12.839.0205.4%
Shares Outstanding (Mil)19183.8%
Cumulative Contribution-37.3%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2025 to 5/13/2026
ReturnCorrelation
USNA-37.3% 
Market (SPY)35.4%36.6%
Sector (XLP)6.4%27.4%

Fundamental Drivers

The -73.5% change in USNA stock from 4/30/2023 to 5/13/2026 was primarily driven by a -87.1% change in the company's Net Income Margin (%).
(LTM values as of)43020235132026Change
Stock Price ($)66.3717.61-73.5%
Change Contribution By: 
Total Revenues ($ Mil)999926-7.3%
Net Income Margin (%)6.9%0.9%-87.1%
P/E Multiple18.439.0111.7%
Shares Outstanding (Mil)19184.5%
Cumulative Contribution-73.5%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2023 to 5/13/2026
ReturnCorrelation
USNA-73.5% 
Market (SPY)85.5%32.9%
Sector (XLP)18.7%24.5%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
USNA Return31%-47%1%-33%-45%-10%-77%
Peers Return5%-44%5%-52%36%-3%-61%
S&P 500 Return27%-19%24%23%16%9%98%

Monthly Win Rates [3]
USNA Win Rate67%17%67%33%33%40% 
Peers Win Rate58%33%46%38%42%55% 
S&P 500 Win Rate75%42%67%75%67%60% 

Max Drawdowns [4]
USNA Max Drawdown-18%-53%-35%-39%-49%-25% 
Peers Max Drawdown-37%-56%-46%-62%-32%-30% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: HLF, NUS, NATR, MED.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/13/2026 (YTD)

How Low Can It Go

EventUSNAS&P 500
2025 US Tariff Shock
  % Loss-24.9%-18.8%
  % Gain to Breakeven33.2%23.1%
  Time to Breakeven76 days79 days
2020 COVID-19 Crash
  % Loss-35.9%-33.7%
  % Gain to Breakeven55.9%50.9%
  Time to Breakeven35 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-11.8%-19.2%
  % Gain to Breakeven13.4%23.7%
  Time to Breakeven20 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-12.0%-3.7%
  % Gain to Breakeven13.7%3.9%
  Time to Breakeven18 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-40.8%-12.2%
  % Gain to Breakeven69.0%13.9%
  Time to Breakeven286 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-24.5%-17.9%
  % Gain to Breakeven32.5%21.8%
  Time to Breakeven67 days123 days

Compare to HLF, NUS, NATR, MED

In The Past

Usana Health Sciences's stock fell -24.9% during the 2025 US Tariff Shock. Such a loss loss requires a 33.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventUSNAS&P 500
2025 US Tariff Shock
  % Loss-24.9%-18.8%
  % Gain to Breakeven33.2%23.1%
  Time to Breakeven76 days79 days
2020 COVID-19 Crash
  % Loss-35.9%-33.7%
  % Gain to Breakeven55.9%50.9%
  Time to Breakeven35 days140 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-40.8%-12.2%
  % Gain to Breakeven69.0%13.9%
  Time to Breakeven286 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-24.5%-17.9%
  % Gain to Breakeven32.5%21.8%
  Time to Breakeven67 days123 days
2008-2009 Global Financial Crisis
  % Loss-50.6%-53.4%
  % Gain to Breakeven102.3%114.4%
  Time to Breakeven421 days1085 days
Summer 2007 Credit Crunch
  % Loss-41.0%-8.6%
  % Gain to Breakeven69.6%9.5%
  Time to Breakeven2084 days47 days

Compare to HLF, NUS, NATR, MED

In The Past

Usana Health Sciences's stock fell -24.9% during the 2025 US Tariff Shock. Such a loss loss requires a 33.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Usana Health Sciences (USNA)

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

AI Analysis | Feedback

Here are 1-3 brief analogies for Usana Health Sciences (USNA):

  • Herbalife for a wider range of science-based nutritional and personal care products.
  • Nu Skin, but focused on comprehensive health and wellness solutions.

AI Analysis | Feedback

  • USANA Nutritional Products (Essentials/CellSentials): Vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups.
  • USANA Nutritional Products (Optimizers): Targeted supplements designed to meet cardiovascular, skeletal/structural, and digestive health needs.
  • USANA Nutritional Products (Foods): Meal replacement shakes, snack bars, and other related food products.
  • Celavive: A comprehensive skin care regimen catering to various skin care types and ethnicities.
  • Products for Prenatal, Infant, and Young Child Age Groups: Specialized nutritional and personal care products tailored for these specific age demographics.
  • Business Support Tools and Materials: Materials and online tools offered to assist associates in building their businesses and marketing products.

AI Analysis | Feedback

Major Customers of USANA Health Sciences (USNA)

USANA Health Sciences operates on a direct selling model, primarily selling its nutritional and personal care products to a global network of independent distributors, referred to as "associates." These associates then resell the products to individual consumers or consume them themselves. Therefore, USANA's direct customers are these individual associates, and the ultimate consumers of its products are individuals. As the company primarily sells products intended for individual use, here are up to three categories of individual customers that it serves:
  • Health and Wellness Enthusiasts: Individuals seeking to support their overall health, vitality, and specific health needs (e.g., cardiovascular, skeletal/structural, digestive health) through daily vitamin and mineral supplements, targeted optimizers, and nutritious food products like meal replacement shakes and snack bars.
  • Skincare and Beauty Conscious Individuals: Consumers interested in maintaining or improving their skin health and appearance, utilizing USANA's Celavive skincare regimen tailored for various skin types and ethnicities.
  • Families, Expectant Mothers, and Parents of Young Children: Customers looking for specialized nutritional support for prenatal care, infants, and young children, ensuring foundational health from an early age.

AI Analysis | Feedback

null

AI Analysis | Feedback

Kevin Guest, Chief Executive Officer and Chairman of the Board

Kevin Guest reassumed the role of Chief Executive Officer of USANA Health Sciences in January 2026, while also continuing as Chairman of the Board. He has a long history with USANA, having been involved with the company since its early days in 1992. Initially, he was a managing partner with FMG Productions, which helped produce USANA's videos and events. When FMG was brought in-house in 2004 to form USANA Studios, Mr. Guest became USANA's Vice President of Media and Events. He later became president in 2014 and Chief Executive Officer in 2015. He also served as Co-Chief Executive Officer from August 2015 to November 2016. In July 2023, he transitioned to Executive Chairman before returning to the CEO position. His entrepreneurial experience with FMG Productions provided him with a unique perspective on the company. Mr. Guest is also a mental health advocate and author of the bestselling book "All the Right Reasons."

G. Douglas Hekking, Chief Financial Officer and Principal Accounting Officer

G. Douglas Hekking serves as the Chief Financial Officer and Principal Accounting Officer of USANA Health Sciences. He was promoted to CFO in May 2017. Mr. Hekking joined USANA in 1992 and has held various management positions, including Controller from 1996 to 2005, and Vice President of Finance. He previously served as CFO from May 2011 to December 2012, stepping aside for family health matters, and then returned to a strategic role. He received a Bachelor of Science in accounting from the University of Utah and a Master of Business Administration from Brigham Young University. In June 2023, he was honored with the CXO of the Year Award by Utah Business Magazine.

Walter Noot, Chief Operating Officer

Walter Noot was appointed Chief Operating Officer in October 2019. He joined USANA in December 2016 as Chief Information Officer. Mr. Noot brings over two decades of executive leadership experience from various industries, including direct selling. Before joining USANA, he served as Chief Information Officer and Senior Vice President of Operations at Young Living Essential Oils, LC, from 2014 to 2016, where he oversaw supply chain improvements and the implementation of a new ERP system. He is responsible for global operations and information technology functions at USANA. He holds a Bachelor of Science degree in mechanical engineering from Brigham Young University.

Robert Sinnott, Chief Scientific Officer

Dr. Robert Sinnott serves as the Chief Scientific Officer of USANA Health Sciences, having joined the company in August 2016. He has more than 25 years of experience in biotechnology, life sciences, and nutrition, with 18 years specifically within the nutritional supplement industry. Prior to USANA, Dr. Sinnott held leadership roles including CEO and Chief Scientific Officer at Mannatech, Inc., and was a co-founder of Larreacorp, Ltd. He manages all aspects of global research and development at USANA. Dr. Sinnott holds a Ph.D. in Biotechnology from Arizona State University and has completed executive education programs at institutions such as Harvard Business School and the Wharton School. He also holds five patents.

Brent L. Neidig, Chief Commercial Officer

Brent L. Neidig was appointed Chief Commercial Officer in July 2023. Before this role, he served as the Executive Vice President of China at USANA Health Sciences. Mr. Neidig initially took on a leadership role at USANA as the executive director of the ethics and education team.

AI Analysis | Feedback

The key risks to Usana Health Sciences (USNA) include:
  1. Challenges with the Direct Selling Model and Declining Active Customers: Usana Health Sciences primarily operates through a direct selling (multi-level marketing) model, which has faced significant hurdles. The company has experienced a decline in its active customer and Brand Partner base, with the recovery of sales productivity under new compensation plans identified as a major risk to the business. The multi-level marketing (MLM) channel has been in structural decline over the past five years, especially among younger consumers who prefer direct-to-consumer (DTC) brands or influencer-led commerce. This decline has contributed to decreasing active customers and net sales for Usana.
  2. Intense Market Competition and Evolving Consumer Behavior: The health and wellness sector is highly competitive, requiring continuous innovation and product differentiation. Usana must constantly adapt to maintain its market position and attract new customers amidst evolving consumer preferences. There is a noted shift in consumer behavior away from traditional direct selling towards other channels.
  3. Regulatory and Trade Uncertainties in International Markets: Operating globally, Usana is exposed to risks from changes in regulations and trade policies, particularly in key international markets like China. These uncertainties can significantly influence cross-border operations and future business plans. China, a crucial market for Usana, has presented a challenging operating environment with declining net sales in some periods, despite an increase in active customers, due to a decrease in average spend per customer.

AI Analysis | Feedback

The clear emerging threat to Usana Health Sciences is the rapid growth and increasing market share of direct-to-consumer (DTC) e-commerce brands in the nutritional, health, wellness, and personal care sectors. These digitally native brands leverage efficient online distribution, targeted digital marketing, and often transparent ingredient sourcing to reach consumers directly, bypassing traditional multi-level marketing structures. This trend directly competes with USANA's reliance on its "associates" and direct selling model by offering consumers a streamlined, often lower-cost, and more convenient purchasing experience for similar product categories.

AI Analysis | Feedback

Here are the addressable market sizes for Usana Health Sciences' main products and services: * Global Dietary Supplements Market: The global dietary supplements market was valued at approximately USD 203.56 billion in 2024 and is projected to reach around USD 435.42 billion by 2034, growing at a CAGR of about 7.9% between 2025 and 2034. North America held over 35% of the global market in 2025, with an estimated market size of USD 65.88 billion. Europe's dietary supplements market was estimated at USD 54.77 billion in 2025, and the Asia Pacific market was around USD 43.24 billion in 2025, projected to reach USD 93.04 billion by 2030. More specifically, the global vitamin and mineral supplement market is valued at USD 65.1 billion in 2026 and is projected to reach USD 110.1 billion by 2036. * Global Meal Replacement Products Market: This market was estimated at USD 21.63 billion in 2023 and is expected to grow to approximately USD 47.49 billion by 2033, with a compound annual growth rate (CAGR) of 8.18% from 2023 to 2033. Another estimate places the global market at USD 23.57 billion in 2024, growing to USD 51.99 billion by 2034, with a CAGR of 8.23% from 2025 to 2034. North America dominated the market in 2024 with a 44% share. * Global Skincare Market: The global skincare market size was valued at USD 122.11 billion in 2025 and is projected to grow to USD 227.13 billion by 2034, exhibiting a CAGR of 7.32% during the forecast period from 2026 to 2034. Asia Pacific dominated this market with a share of 51.46% in 2025. * Global Infant and Young Child Nutrition Market: The global infant nutrition market size was valued at USD 52.80 billion in 2024 and is projected to reach USD 110.15 billion by 2033, growing at a CAGR of 8.5% during the forecast period (2025–2033). Asia-Pacific is the largest shareholder in the global infant nutrition market. Another source indicates the global infant nutrition market size was approximately USD 60.1 billion in 2025 and is projected to reach around USD 158.11 billion by 2035, expanding at a CAGR of 10.15% between 2026 and 2035.

AI Analysis | Feedback

Usana Health Sciences (USNA) is expected to drive future revenue growth over the next two to three years through a multi-faceted strategy that includes strategic acquisitions, continuous product innovation, the expansion of its newer brands, geographic market penetration, and the evolution of its sales model.

Drivers of Future Revenue Growth:

  • Acquisition and Growth of Hiya Health Products: The acquisition of a controlling stake in Hiya Health Products in December 2024 positions USANA to significantly expand its presence in the children's wellness market. This subscription-based, direct-to-consumer (DTC) brand is projected to be a substantial contributor to net sales in fiscal years 2025 and 2026, and is accelerating USANA's shift to an omnichannel retail model.
  • New Product Launches and Enhanced Formulations: USANA consistently introduces new products and upgrades existing ones within its core nutritional and personal care lines. Recent examples include the August 2024 launch of the Celavive Resurfacing Serum and Whey Protein Isolate. Furthermore, 2025 saw the introduction of innovative products such as Circulate+, Core Aminos, and Marine Collagen Peptides, alongside several new and reformulated Celavive skincare products. These innovations aim to broaden product appeal and meet evolving consumer demands.
  • Expansion of "Rise Wellness" Brand: The "Rise Wellness" brand, encompassing products like Rise Bar and Protein Pop, is anticipated to experience notable growth. USANA is making strategic investments to support the expansion of this brand into new online marketplaces and retail channels, contributing to its overall sales outlook for fiscal 2026.
  • Geographic Market Expansion: USANA continues to pursue international growth opportunities. A significant move was its expansion into India in the latter half of 2023, representing its first new market in five years, with expectations for long-term growth. The company is also emphasizing growth initiatives in China and exploring other new international markets.
  • Revamped Brand Partner Compensation Plan and Omni-channel Strategy: To stimulate customer growth and retention, USANA implemented a revamped Brand Partner Compensation Plan in 2025. Concurrently, the company is accelerating its transition to an omni-channel sales model, which integrates its traditional direct selling approach with direct-to-consumer channels, third-party marketplaces, and retail presence, thereby aiming to expand its reach to a wider customer base.

AI Analysis | Feedback

Here is a summary of Usana Health Sciences' capital allocation decisions over the last 3-5 years:

Share Repurchases

  • The company's Board of Directors increased its share repurchase authorization to $150 million in September 2021, inclusive of $14 million remaining under the previous authorization.
  • As of December 28, 2024, approximately $62 million remained under the current share repurchase authorization.
  • From September 28, 2025, to January 3, 2026, the company did not repurchase any shares.

Share Issuance

  • USANA's shares outstanding have shown a decreasing trend over the last few years, from 0.021 billion at the end of March 2021 to 0.018 billion by September 2025, indicating net repurchases rather than issuances.
  • The number of shares outstanding decreased by 3.07% in one year.

Outbound Investments

  • In December 2024, USANA acquired a 78.8% controlling stake in Hiya Health Products, LLC, a children's health and wellness company, for $205 million in cash. This acquisition aims to broaden USANA's reach into the direct-to-consumer channel.
  • In November 2022, USANA acquired Rise Bar (now Rise Wellness) and Oola Life; the acquisition prices for these were undisclosed.
  • The Hiya acquisition is expected to contribute $145 million to $160 million in net sales for fiscal year 2025 and be immediately accretive to 2025 adjusted EBITDA.

Capital Expenditures

  • USANA consistently invests in research and development, allocating approximately $25 million in fiscal year 2024.

Better Bets vs. Usana Health Sciences (USNA)

Trade Ideas

Select ideas related to USNA.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ELF_4102026_Dip_Buyer_FCFYield04102026ELFe.l.f. BeautyDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-1.8%-1.8%-6.2%
IPAR_4022026_Dip_Buyer_ValueBuy04022026IPARInterparfumsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
0.7%0.7%-0.3%
COKE_4022026_Quality_Momentum_RoomToRun_10%04022026COKECoca-Cola ConsolidatedQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
5.5%5.5%-5.2%
MZTI_3272026_Dip_Buyer_FCFYield03272026MZTIMarzettiDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-5.0%-5.0%-8.6%
TAP_3272026_Dip_Buyer_FCFYield03272026TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
-1.5%-1.5%-2.3%
USNA_11302018_Quality_Momentum_RoomToRun_10%11302018USNAUsana Health SciencesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
-42.2%-39.9%-51.9%
USNA_2282017_Quality_Momentum_RoomToRun_10%02282017USNAUsana Health SciencesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
1.7%31.6%-6.5%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

USNAHLFNUSNATRMEDMedian
NameUsana He.HerbalifeNu Skin .Natures .Medifast  
Mkt Price17.6113.006.2822.3312.4813.00
Mkt Cap0.31.30.30.40.10.3
Rev LTM9265,1331,441490346926
Op Inc LTM494978228-1649
FCF LTM33744223-123
FCF 3Y Avg3724264213237
CFO LTM174477631431
CFO 3Y Avg50348110303850

Growth & Margins

USNAHLFNUSNATRMEDMedian
NameUsana He.HerbalifeNu Skin .Natures .Medifast  
Rev Chg LTM5.7%3.7%-14.2%7.3%-36.3%3.7%
Rev Chg 3Y Avg-1.5%0.1%-11.8%5.3%-39.0%-1.5%
Rev Chg Q0.3%7.8%-12.0%8.5%-34.3%0.3%
QoQ Delta Rev Chg LTM0.1%1.9%-3.0%2.0%-10.3%0.1%
Op Inc Chg LTM-14.4%13.7%63.0%29.9%-156.9%13.7%
Op Inc Chg 3Y Avg-20.6%4.4%-2.4%25.5%-106.9%-2.4%
Op Mgn LTM5.3%9.7%5.7%5.7%-4.7%5.7%
Op Mgn 3Y Avg7.3%8.5%3.9%5.2%1.0%5.2%
QoQ Delta Op Mgn LTM-0.2%0.1%-0.5%0.6%-1.0%-0.2%
CFO/Rev LTM1.8%8.7%5.3%6.3%1.1%5.3%
CFO/Rev 3Y Avg5.6%6.9%6.4%6.5%5.0%6.4%
FCF/Rev LTM0.3%7.3%2.9%4.7%-0.4%2.9%
FCF/Rev 3Y Avg4.2%4.8%3.8%4.5%3.8%4.2%

Valuation

USNAHLFNUSNATRMEDMedian
NameUsana He.HerbalifeNu Skin .Natures .Medifast  
Mkt Cap0.31.30.30.40.10.3
P/S0.30.30.20.80.40.3
P/Op Inc6.62.73.713.9-8.53.7
P/EBIT7.92.73.812.6-8.53.8
P/E39.05.65.619.7-6.95.6
P/CFO19.53.04.012.737.012.7
Total Yield2.6%17.7%21.9%5.1%-14.5%5.1%
Dividend Yield0.0%0.0%3.9%0.0%0.1%0.0%
FCF Yield 3Y Avg5.6%20.7%14.2%6.2%9.4%9.4%
D/E0.01.60.90.10.10.1
Net D/E-0.51.30.3-0.2-1.1-0.2

Returns

USNAHLFNUSNATRMEDMedian
NameUsana He.HerbalifeNu Skin .Natures .Medifast  
1M Rtn-3.1%-16.3%-16.4%-16.5%17.4%-16.3%
3M Rtn-16.7%-21.5%-37.8%-14.6%15.0%-16.7%
6M Rtn-9.1%39.3%-33.7%7.9%7.3%7.3%
12M Rtn-40.8%90.9%-13.3%55.8%-1.9%-1.9%
3Y Rtn-73.0%-7.3%-81.2%110.3%-85.4%-73.0%
1M Excs Rtn-11.7%-28.9%-25.7%-23.6%7.9%-23.6%
3M Excs Rtn-23.9%-28.7%-45.1%-21.8%7.8%-23.9%
6M Excs Rtn-17.1%34.7%-44.5%3.9%-3.1%-3.1%
12M Excs Rtn-68.7%56.8%-40.8%27.3%-32.3%-32.3%
3Y Excs Rtn-153.4%-87.4%-161.6%28.4%-165.4%-153.4%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Core nutritional8469159951,186 
Other764 11
Hiya direct-to-consumer2    
Personal care and Skincare    79
USANA Foods    79
USANA Nutritionals    964
Total8559219991,1861,135


Operating Income by Segment
$ Mil20252024202320222021
Core nutritional7196   
Hiya direct-to-consumer0    
Other-5-3   
Total6693   


Price Behavior

Price Behavior
Market Price$17.61 
Market Cap ($ Bil)0.3 
First Trading Date02/01/1995 
Distance from 52W High-50.3% 
   50 Days200 Days
DMA Price$18.23$22.29
DMA Trenddowndown
Distance from DMA-3.4%-21.0%
 3M1YR
Volatility49.1%46.3%
Downside Capture132.01157.06
Upside Capture25.7948.36
Correlation (SPY)28.8%35.2%
USNA Betas & Captures as of 4/30/2026

 1M2M3M6M1Y3Y
Beta1.111.110.890.841.320.86
Up Beta0.360.941.260.731.230.67
Down Beta11.221.171.701.112.441.01
Up Capture115%68%27%68%46%24%
Bmk +ve Days15223166141428
Stock +ve Days14233260112351
Down Capture473%161%82%87%127%106%
Bmk -ve Days4183056108321
Stock -ve Days8203265138393

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with USNA
USNA-40.9%46.3%-0.99-
Sector ETF (XLP)7.5%12.7%0.3027.4%
Equity (SPY)28.9%12.0%1.8235.7%
Gold (GLD)44.6%26.8%1.35-1.6%
Commodities (DBC)47.8%18.6%1.96-18.4%
Real Estate (VNQ)11.3%13.5%0.5537.9%
Bitcoin (BTCUSD)-21.3%41.7%-0.4619.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with USNA
USNA-29.0%35.9%-0.87-
Sector ETF (XLP)6.5%13.2%0.2726.3%
Equity (SPY)13.7%17.1%0.6333.3%
Gold (GLD)20.4%17.9%0.934.9%
Commodities (DBC)11.1%19.4%0.46-4.2%
Real Estate (VNQ)3.6%18.8%0.0933.8%
Bitcoin (BTCUSD)7.5%55.9%0.3516.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with USNA
USNA-5.5%49.8%0.04-
Sector ETF (XLP)7.7%14.7%0.3922.3%
Equity (SPY)15.6%17.9%0.7528.5%
Gold (GLD)13.4%15.9%0.702.8%
Commodities (DBC)8.3%17.9%0.385.9%
Real Estate (VNQ)5.4%20.7%0.2225.9%
Bitcoin (BTCUSD)68.2%66.9%1.078.2%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date4302026
Short Interest: Shares Quantity0.5 Mil
Short Interest: % Change Since 41520265.0%
Average Daily Volume0.1 Mil
Days-to-Cover Short Interest5.3 days
Basic Shares Quantity18.4 Mil
Short % of Basic Shares2.7%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/5/20263.9%-9.9% 
1/12/20263.8%10.5%8.0%
10/9/2025-22.8%-19.7%-27.1%
7/22/202512.4%-4.0%-1.3%
2/25/20253.9%-7.4%-14.8%
10/22/20246.1%8.2%14.6%
7/23/2024-3.2%-4.9%-13.1%
4/30/20249.7%7.8%12.5%
...
SUMMARY STATS   
# Positive14129
# Negative91113
Median Positive4.5%6.2%8.0%
Median Negative-6.8%-7.4%-8.2%
Max Positive13.0%10.5%14.6%
Max Negative-22.8%-19.7%-27.1%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/12/202610-Q
12/31/202503/16/202610-K
09/30/202511/05/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202403/12/202510-K
09/30/202411/05/202410-Q
06/30/202408/06/202410-Q
03/31/202405/07/202410-Q
12/31/202302/27/202410-K
09/30/202311/07/202310-Q
06/30/202308/08/202310-Q
03/31/202305/09/202310-Q
12/31/202202/28/202310-K
09/30/202211/08/202210-Q
06/30/202208/09/202210-Q

Recent Forward Guidance [BETA]

Latest: Q1 2026 Earnings Reported 5/5/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Core Nutritional business net sales720.00 Mil742.50 Mil765.00 Mil0 AffirmedGuidance: 742.50 Mil for 2026
2026 Hiya net sales140.00 Mil147.50 Mil155.00 Mil0 AffirmedGuidance: 147.50 Mil for 2026
2026 Rise Wellness net sales65.00 Mil72.50 Mil80.00 Mil0 AffirmedGuidance: 72.50 Mil for 2026
2026 Consolidated net sales925.00 Mil962.50 Mil1.00 Bil0 AffirmedGuidance: 962.50 Mil for 2026
2026 Net earnings20.00 Mil23.50 Mil27.00 Mil0.2% RaisedGuidance: 23.45 Mil for 2026
2026 Diluted EPS1.111.281.450 AffirmedGuidance: 1.28 for 2026
2026 Adjusted diluted EPS1.952.122.290 AffirmedGuidance: 2.12 for 2026
2026 Adjusted EBITDA101.00 Mil105.00 Mil109.00 Mil-0.3% LoweredGuidance: 105.30 Mil for 2026

Prior: Q4 2025 Earnings Reported 2/18/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Consolidated Net Sales925.00 Mil962.50 Mil1.00 Bil4.6% Higher NewActual: 920.00 Mil for 2025
2026 Core nutritional business net sales720.00 Mil742.50 Mil765.00 Mil-5.8% Lower NewActual: 788.00 Mil for 2025
2026 Hiya net sales140.00 Mil147.50 Mil155.00 Mil11.7% Higher NewActual: 132.00 Mil for 2025
2026 Rise Wellness net sales65.00 Mil72.50 Mil80.00 Mil   
2026 Net earnings20.30 Mil23.45 Mil26.60 Mil56.3% Higher NewActual: 15.00 Mil for 2025
2026 Diluted EPS1.111.281.4564.1% Higher NewActual: 0.78 for 2025
2026 Adjusted diluted EPS1.952.122.2922.5% Higher NewActual: 1.73 for 2025
2026 Adjusted EBITDA101.30 Mil105.30 Mil109.30 Mil7.4% Higher NewActual: 98.00 Mil for 2025

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Foukas, JoshuaCHIEF LEGAL OFFICERDirectSell508202619.823,791  Form
2Fuller, Gilbert ADirectSell320202617.001,058  Form
3Benedict, PeterCHIEF INFORMATION OFFICERDirectSell304202619.384,553  Form
4Foukas, JoshuaCHIEF LEGAL OFFICERDirectSell223202621.344,461  Form
5Mulham, David MulhamCHIEF SALES OFFICERDirectSell1211202521.0087318,333176,127Form

Industry Resources

Packaged Foods & Meats Resources
USDA Data